Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Diabetes Care|September 20, 2012
Frequency and severity of the dawn phenomenon in type 2 diabetes: relationship to ageLouis Monnier, Claude Colette, Mathieu Sardinoux, et al.Diabetes Research and Clinical Practice|July 4, 2025
Glycemic variability and iatrogenic hypoglycemia: how to resolveLouis Monnier, Claude Colette, Eric Renard, et al.JAMA|April 13, 2006
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetesLouis Monnier, Emilie Mas, Christine Ginet, et al.Diabetes Care|March 29, 2002
Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetesLouis Monnier, Claude Colette, Rémy Rabasa-Lhoret, et al.Diabetes Care|January 1, 2017
Toward Defining the Threshold Between Low and High Glucose Variability in DiabetesLouis Monnier, Claude Colette, Anne Wojtusciszyn, et al.Diabetes & Metabolism|November 24, 2024
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variabilityLouis Monnier, Claude Colette, Eric Renard, et al.Expert Opinion on Drug Metabolism & Toxicology|November 4, 2016
Individualized, patient-centered use of lixisenatide for the treatment of type 2 diabetes mellitusMarkolf Hanefeld, Denis Raccah, Louis MonnierThe Lancet. Diabetes & Endocrinology|August 18, 2018
Glycaemic variability in diabetes: clinical and therapeutic implicationsAntonio Ceriello, Louis Monnier, David OwensJournal of Diabetes Science and Technology|May 31, 2014
Self-monitoring of blood glucose: a prerequisite for diabetes management in outcome trialsOliver Schnell, Markolf Hanefeld, Louis MonnierDiabetes/Metabolism Research and Reviews|September 13, 2013
Basal insulin analogues in the management of diabetes mellitus: What progress have we made?David R Owens, Glenn Matfin, Louis MonnierPageof 5